This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Case Reports

. 2007 Oct;151(4):441, 441.e1.

doi: 10.1016/j.jpeds.2007.02.066.

Cortical hyperostosis secondary to prostaglandin E1 therapy

Kimberly Estes¹, Michael Nowicki, Phyllis Bishop

Affiliations

PMID: 17889087
DOI: 10.1016/j.jpeds.2007.02.066

Case Reports

Cortical hyperostosis secondary to prostaglandin E1 therapy

Kimberly Estes et al. J Pediatr. 2007 Oct.

. 2007 Oct;151(4):441, 441.e1.

doi: 10.1016/j.jpeds.2007.02.066.

Authors

Kimberly Estes¹, Michael Nowicki, Phyllis Bishop

Affiliation

¹ Division of Pediatric Gastroenterology, University of Mississippi Medical Center, Jackson, Mississippi 39216, USA.

PMID: 17889087
DOI: 10.1016/j.jpeds.2007.02.066

No abstract available

PubMed Disclaimer

Similar articles

Cortical hyperostosis simulating osteomyelitis after short-term prostaglandin E1 infusion.
Kalloghlian AK, Frayha HH, deMoor MM. Kalloghlian AK, et al. Eur J Pediatr. 1996 Mar;155(3):173-4. doi: 10.1007/BF01953932. Eur J Pediatr. 1996. PMID: 8929722
[Neonatal cortical hyperostosis. A side effect of prolonged prostaglandin E1 infusion].
Fernández MA, Gebara E. Fernández MA, et al. Arch Argent Pediatr. 2011 Apr;109(2):154-9. doi: 10.1590/S0325-00752011000200011. Arch Argent Pediatr. 2011. PMID: 21465075 Spanish.
Reversibility of cortical hyperostosis following long-term prostaglandin E1 therapy in infants with ductus-dependent congenital heart disease.
Høst A, Halken S, Andersen PE Jr. Høst A, et al. Pediatr Radiol. 1988;18(2):149-53. doi: 10.1007/BF02387559. Pediatr Radiol. 1988. PMID: 3281113
Neonatal cortical hyperostosis.
Carey BE. Carey BE. Neonatal Netw. 2000 Oct;19(7):55-7. doi: 10.1891/0730-0832.19.7.55. Neonatal Netw. 2000. PMID: 11949025 Review. No abstract available.
Prostaglandin-induced cortical hyperostosis. Case report and review of the literature.
Gardiner JS, Zauk AM, Donchey SS, McInerney VK. Gardiner JS, et al. J Bone Joint Surg Am. 1995 Jun;77(6):932-6. doi: 10.2106/00004623-199506000-00014. J Bone Joint Surg Am. 1995. PMID: 7782366 Review. No abstract available.

See all similar articles

Cited by

The Osteogenesis Imperfecta Type V Mutant BRIL/IFITM5 Promotes Transcriptional Activation of MEF2, NFATc, and NR4A in Osteoblasts.
Maranda V, Gaumond MH, Moffatt P. Maranda V, et al. Int J Mol Sci. 2022 Feb 15;23(4):2148. doi: 10.3390/ijms23042148. Int J Mol Sci. 2022. PMID: 35216266 Free PMC article.
Two Japanese familial cases of Caffey disease with and without the common COL1A1 mutation and normal bone density, and review of the literature.
Kitaoka T, Miyoshi Y, Namba N, Miura K, Kubota T, Ohata Y, Fujiwara M, Takagi M, Hasegawa T, Jüppner H, Ozono K. Kitaoka T, et al. Eur J Pediatr. 2014 Jun;173(6):799-804. doi: 10.1007/s00431-013-2252-8. Epub 2014 Jan 4. Eur J Pediatr. 2014. PMID: 24390061 Review.
Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions.
Akkinapally S, Hundalani SG, Kulkarni M, Fernandes CJ, Cabrera AG, Shivanna B, Pammi M. Akkinapally S, et al. Cochrane Database Syst Rev. 2018 Feb 27;2(2):CD011417. doi: 10.1002/14651858.CD011417.pub2. Cochrane Database Syst Rev. 2018. PMID: 29486048 Free PMC article.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions

LinkOut - more resources

Full Text Sources